STAAR Surgical Company (STAA)
Quick ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 144,159 | 183,038 | 86,480 | 199,706 | 152,453 |
Short-term investments | US$ in thousands | 86,335 | 37,688 | 125,159 | 0 | — |
Receivables | US$ in thousands | — | — | — | — | — |
Total current liabilities | US$ in thousands | 70,306 | 65,036 | 51,716 | 48,802 | 41,236 |
Quick ratio | 3.28 | 3.39 | 4.09 | 4.09 | 3.70 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($144,159K
+ $86,335K
+ $—K)
÷ $70,306K
= 3.28
The quick ratio of STAAR Surgical Company has shown a generally positive trend over the past five years. The ratio increased from 3.70 in December 31, 2020, to 4.09 in December 31, 2021, where it remained stable through December 31, 2022. However, there was a slight decline in the quick ratio to 3.39 by December 31, 2023, followed by a further decrease to 3.28 as of December 31, 2024.
Overall, the quick ratio above 1 indicates that STAAR Surgical Company has a strong ability to meet its short-term obligations using its highly liquid assets. Despite the recent decline, the company still maintains a healthy level of liquid assets relative to its current liabilities, suggesting a good financial position to address any immediate financial needs.
Peer comparison
Dec 31, 2024